Trulieve Cannabis Corp Stock EBITDA

TCNNF Stock  USD 12.10  0.05  0.41%   
Trulieve Cannabis Corp fundamentals help investors to digest information that contributes to Trulieve Cannabis' financial success or failures. It also enables traders to predict the movement of Trulieve OTC Stock. The fundamental analysis module provides a way to measure Trulieve Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trulieve Cannabis otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Trulieve Cannabis Corp OTC Stock EBITDA Analysis

Trulieve Cannabis' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Trulieve Cannabis EBITDA

    
  276.51 M  
Most of Trulieve Cannabis' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trulieve Cannabis Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Trulieve Cannabis Corp reported earnings before interest,tax, depreciation and amortization of 276.51 M. This is 68.49% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 92.91% higher than that of the company.

Trulieve EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trulieve Cannabis' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Trulieve Cannabis could also be used in its relative valuation, which is a method of valuing Trulieve Cannabis by comparing valuation metrics of similar companies.
Trulieve Cannabis is currently under evaluation in ebitda category among its peers.

Trulieve Cannabis ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Trulieve Cannabis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Trulieve Cannabis' managers, analysts, and investors.
Environmental
Governance
Social

Trulieve Fundamentals

About Trulieve Cannabis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Trulieve Cannabis Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trulieve Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trulieve Cannabis Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Trulieve OTC Stock

Trulieve Cannabis financial ratios help investors to determine whether Trulieve OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Trulieve with respect to the benefits of owning Trulieve Cannabis security.